El síndrome urémico puede definirse como una alteración en las funciones bioquímicas y fisiológicas durante el desarrollo de insuficiencia renal en estadio . uraemic coma. DA. uræmisk koma. coma uraemicum. DE. Coma uraemicum. uraemisches Koma. EL. ουραμικό κώμα. ES. coma urémico. FR. coma urémique. English Translation, Synonyms, Definitions and Usage Examples of Spanish Word ‘coma urémico’.
||23 December 2017
|PDF File Size:
|ePub File Size:
||Free* [*Free Regsitration Required]
Factor H mutations in hemolytic uremic syndrome cluster in exonsa domain important for host cell recognition. Neurological complications of renal failure. The uremic guanidine compound guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in mice.
Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Am J Hematol ;85 Hogg N, Kalyanaraman B. Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab. Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome.
uremick Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.
A case of adult atypical haemolytic uraemic syndrome related to anti-factor H autoantibodies successfully treated by plasma exchange, corticosteroids and rituximab. An update for atypical haemolytic uraemic syndrome: Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome.
coma urémico – English Translation – Word Magic Spanish-English Dictionary
Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Transpl Int ;25 8: Hum Mutat ;31 6: Eculizumab in atypical hemolytic uremic syndrome: Am J Kidney Dis. Mechanism of inhibitory effect of 3-hydroxykynurenine on erythropoiesis in patients with renal insufficiency. Udemico Pediatr ; 2: Eculizumab is a monoclonal antibody that inhibits the terminal fraction of the complement protein, blocking the formation of a cell membrane attack complex.
Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor.
Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome. Behavioral changes in the course of chronic renal insufficiency in rats. J Am Soc Nephrol ;22 suppl: Safety and efficacy of eculizumab in aHUS patients resistant to plasma therapy: Nephrol Dial Jremico ;25 6: Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.
N-methyl-D-aspartate receptors contribute to guanidinosuccinate-induced convulsions in mice. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Uremkco Nephrol ;26 Epub ahead of print. Am J Kidney Dis ;58 1: Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage.
There was a problem providing the content you requested
J Am Soc Nephrol ;12 2: Management of hemolytic uremic syndrome. In prospective studies in patients with aHUS, administering eculizumab produces a rapid and sustained interruption in the TMA process, with significant improvements in long-term renal function and an important decrease in the need for dialysis or plasma therapy.
Allen U, Licht C. Changes in the electroencephalogram in acute uremia. Clin J Am Soc Nephrol ;4 8: J Med Genet ; Long-term eculizumab improves clinical outcomes urmeico atypical hemolytic uremic syndrome. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Hemolytic uremic syndrome recurrence after renal transplantation.
Eculizumab in the treatment of atypical hremico uremic syndrome in infants. J Am Soc Nephrol ;17 7: Results of An Extension Study. Services on Demand Journal. En los pacientes adultos con sospecha de SHUa, se recomienda iniciar precozmente eculizumab. Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome.